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1 INTRODUCTION 
 
Scalp cooling is a method used to reduce hair loss 
for patients undergoing chemotherapy treatment. 
Many patients experience great concern over the 
possibility of hair loss, which is a constant reminder 
of the disease to the patient, their family and in the 
wider social environment of work and leisure. Scalp 
cooling reduces hair loss with many prescribed 
chemotherapy drugs. It can result in a high level of 
retention or complete hair preservation which can 
improve patient’s self-confidence leading to a posi-
tive attitude to their treatment and recovery. (Pax-
man 2015)  
 
Benefits and Features of Scalp Cooling are:  
 Greatly reduces the risk of hair loss, 
 Preserves self-image,  
 Allows continued social activities,  
 Maintains the scalp at a constant temperature, 
 Comfortable and pain free, 
 High level of patient tolerance and acceptability. 
 
The research team and Paxman group have been col-
laborating for over five years, primarily around the 
development of a unique product, namely a mass 
manufacturable scalp cooling cap using 3D anthro-
pometric human head data.  The research group ini-
tially worked on the chemical processes around the 
treatment which was explored through a previous 
KTP in the Biology Department, (Al-Tameemi et al, 
2014) where the research helped deeper understand 
the science behind the treatment, leading to further 
improvements in the globally-marketed cap. Initial 
research showed that there is a demand for a new cap 
which requires redesign of the cap shape to suit local 
anthropometric variances with improved cap produc-
tion methods. 
 
2 BACKGROUND OF MEDICAL RESEARCH 
ON SCALP COOLING 
The Paxman Hair Loss Prevention System provides 
cooling for one or two patients simultaneously with 
each cap working independently during chemothera-
py. The system consists of a small compact refrigera-
tion unit containing a special coolant which is circu-
lated at -4°C through coolant lines to specially 
designed cooling caps. It is simple to operate and can 
monitor cooling parameters using a touch screen 
display. 
Fig 1. Paxman Cooling Cap (Paxman.de, 2016) 
  
2.1 Cooling Caps 
 
The most important feature of the Paxman Hair Loss 
Prevention System is the specially designed light-
weight cooling caps. The caps are soft, flexible and 
provide a snug, close fit around the patient’s head, 
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the 5 different cap sizes in the range are colour cod-
ed and ensure most head shapes are catered. Coolant 
passes through the cap, extracting heat from the pa-
tient’s scalp. Inline temperature sensors ensure the 
cap maintains the scalp at an even, constant tempera-
ture. (Paxman, 2015) 
 
2.2 Procedure 
Scalp cooling works by inducing vasoconstriction 
and reduction of metabolism. Vasoconstriction leads 
to reduced blood flow to the hair follicles in the pe-
riod of peak plasma concentration of the relevant 
chemotherapy agents. In the past decades, scalp 
cooling has been achieved by a number of tech-
niques, such as simple bags with crushed ice, frozen 
cryogel packs, and packs with an endothermic cool-
ing reaction. Examples of precooled caps are 
ChemoCap™ (ChemoCap,Canada), Elasto-Gel™ 
Cold Caps (Southwest Technologies, Akromed Inc.) 
and Penguin Cold Caps (Medical Specialities Of 
California). Cooling machines that use liquid circu-
lation are the systems of Paxman (PCS-1 and 2, Or-
bis) and Dignitana (DigniCap™), while Amit 
Technology (SCSII™) uses chilled air.  
The success of the treatment is affected by the de-
gree of control in maintaining the scalp at a constant 
temperature. The machine is switched on and al-
lowed to reach its operating temperature, which 
takes approximately 30 to 40 minutes. A cooling cap 
connected to the system is then placed on the pa-
tients head. Pre-cooling of the scalp takes 20 to 30 
minutes prior to drug infusion. This ensures the 
scalp is at the required temperature before chemo-
therapy is administered. Patient preparations can 
take place during the pre-cooling period. The cap 
continues to be worn throughout the administration 
of the chemotherapy drugs and for a period of time 
afterwards, depending on the drug regime being ad-
ministered  
 
2.3 Research into Effectiveness of Scalp Cooling 
 
Chemotherapy in the treatment of cancer relies for 
its effectiveness on the ability of the drugs to attack 
rapidly dividing cells which may be both malignant 
and normal. Certain drugs, or chemotherapy may 
cause partial or total atrophy of the hair root bulb, 
causing the hair shaft to break off spontaneously. 
The hair may also be weakened, by a narrowing of 
the hair shaft adjacent to the scalp this has been sug-
gested as associated most frequently with standard 
doses of chemotherapy.  Measures to reduce or elim-
inate alopecia during chemotherapy have been inves-
tigated since the 1960s. There are few studies com-
paring different methods of scalp cooling, but one 
study has suggested that cold air circulation is more 
effective than cryogel packs, as a lower temperature 
can be maintained for a longer period. (Massey SM, 
2004) 
 
2.4 Scalp Cooling Clinical Trials 
Paxman Scalp Cooling experiment in UK (1997-
2010), observational study reports an 89% success 
rate following use of the Paxman System in breast 
cancer patients, with only 11% with severe hair loss 
requiring wigs. Patients reported high comfort and 
acceptability levels with low numbers of withdraw-
als from scalp cooling.  85% of patients reported 
they were comfortable, reasonably comfortable, or 
very comfortable during the scalp-cooling period. 
(Paxman, 2013). Netherland studies (2006 - 2010), 
involved 1411 cancer patients from 11 hospitals in 
the Netherlands, carried out in 2 phases, to deter-
mine the effectiveness and tolerance of scalp cool-
ing. Randomized study in the Netherlands shows 
that a reduction in scalp cooling time to 45 minutes, 
did not reduce the effectiveness of the PSCS (Pax-
man Scalp Cooling System) in preventing hair loss 
in docetaxel treated cancer patients. (Van Den Hurk 
et al. 2012 & 2013) 
Massey SM (2004) Research, studied to determine 
the efficacy and patient acceptability of scalp cooling 
using the Paxman Scalp Cooler. This was an open, 
non-randomized, observational study conducted at 
eight sites involving 94 patients. The study describes 
the use of Paxman scalp cooler and states that a 
scalp temperature below 15 to 22C is required for 
hair preservation. A pre-cooling time of 15– 20 
minutes was recommended to allow time for an ade-
quate reduction in scalp temperature. (Massey SM, 
2004). Research by Komen et al (2011), provides an 
overview of the incidence and severity, presentation 
and impact of chemotherapy-induced alopecia 
(CIA), one of the most common and distressing side 
effects of cancer therapy. Prevention of CIA by scalp 
cooling is described, as well as suggestions for im-
provement of scalp cooling application and clinical 
research approaches. Scalp cooling is described as 
effective but not for all chemotherapy patients and it 
is recommended that scalp cooling should be availa-
ble in every hospital, and every suitable patient 
should be given the opportunity. (Komen et al, 2011 
& 2013) 
 
3 EXPERIMENTS: DESIGN AND 
DEVELOPMENT OF THE SCALP COOLING 
CAP 
 
3.1 Project Aims and Objectives 
 
The aim of the project was to produce a working 
prototype cap to fit initially to a single UK head size 
to allow testing of performance,  and then develop 
the new cap further to meet all the performance re-
quirements but also to fit the variety of head sizes 
and shapes for a global product. The cap must meet 
the following criteria: 
 
o Improve Conductivity, 
o Improve Cap Fit, Comfort & Ergonomics, 
o Improve the Ability to Mass-Produce. 
 
3.2 Application of Rapid Tooling for Silicone 
Forming 
 
The term “Rapid Tooling” (RT) is mostly used for 
prototyping and rapid manufacturing whereas Rapid 
Prototyping (RP) is typically used for visual design 
evaluation or physical and functional verification. 
RP provides an effective communication between 
design, management and marketing teams. Additive 
Manufacturing (AM), mostly using laser sintering 
technology, has been also adopted in industries such 
as aviation and aerospace. (Durgun et al, 2016) 
 
3.3 Medical Device Materials 
 
The biocompatibility of medical devices can be de-
fined as the ability of the device to perform its in-
tended function without causing undesirable side ef-
fects. Biocompatibility will be dependent on 
physical properties of the device and its chemical na-
ture, as well as the body’s reaction to the device that 
will affect its function. Common Medical Device 
Polymers include: Polyethylene, Polypropylene and 
Thermoset Elastomers—Silicone. (Medical Plastics, 
2013) 
Materials that the team could choose from was lim-
ited by current regulations from, UK, EU and FDA 
approval bodies, thus from analysis the team decided 
to use Silicone as unlike latex, most healthcare sili-
cones contain no proteins and are non-allergenic. 
Unlike PVC, they contain no phthalates or other or-
ganic plasticizers which might leach out.   
3.4 Patent Search and Head Size Ergonomic Data 
 
Patent research is key part of a product development 
process. There are number of patents covering vari-
ous innovation in thermal head cooler exchange.  As 
well as UK, EU and relevant American patents are 
investigated for initial design process. Intellectual 
Property office of UK also recently started offering 
Design Registration and Search functionality to their 
online facilities. 
 
The research team evaluated where and what type of 
3D Anthropometric data could be obtained. Data-
bases such as the CAESAR project, the North Amer-
ican and the European edition (CAESAR, 2002) and 
the SizeChina Project (SizeChina, 2007) were inves-
tigated, all databases includes measurements from 
approximately 2400 males and females and include 
both 3-D scans and traditional 1-D measurements.  
Fig 2. Comparison of European to Asian Head Sizes 
(Ball et al, 2010) 
 
The design of consumer products that are worn on 
the head relies on the availability of accurate anthro-
pometric information describing the shape and size 
of the human head and face. Historical anthropomet-
ric studies with univariate data have documented the 
existence of shape differences between Asian and 
Western head shapes, but the information available 
to designers has traditionally been based on only 
Western data. As a result, Asian users have often 
experienced poor fit in products used on the head. In 
addition, the geometry of the head is complex, mak-
ing traditional univariate data unsatisfactory as a de-
scription for its form, as it typically includes only 
numerical values for head length, head width and 
circumference.  
 
4 DESIGN AND DEVELOPMENT 
The following are the considerations during the de-
sign and development phase: 
 
Patient Flexibility: Due to the lightweight nature of 
the caps, patients should relax during the cooling 
process, engage in a number of activities and visit 
the bathroom without affecting their treatment. 
 
Nursing Flexibility: The system and the cap must 
be simple to operate with easy to read digital dis-
plays. The equipment must be compact and maneu-
verable, nursing staff do not need to be in attendance 
with patients during cooling. 
 
Termination of Cooling: On completion of cooling, 
a nurse should assist with the removal of the cap. 
The patient is then left to acclimatize before leaving 
the hospital.   
 
Phase one of this project requires designing a new 
method for creating caps which will fit a selected in-
dividual better than the current standard model but 
also adjustable so cap size number will be reduced 
from five to three. The team decided to create mid-
dle size of the products which is the standard size.  
Having a standard size head, a staff volunteered to 
be 3D scanned to create a 3D head as seen in the fig-
ure below.  
Fig 3. 3D Data from Paxman Staff (Unver, 2013) 
 
The team then developed a manufacturing system for 
creating mass manufactured silicone cap. Some of 
these development phases are explained initially 
such as creation of 3D tubes around the head to 
demonstrate the idea of water flowing through the 
tubes. 
This work proved that the channels can be created to 
fit the scan data. But the method to create a mould 
form sheet silicon was the first challenge. After this 
initial work the team met for a brain storming ses-
sion, where a number of potential directions were 
discussed.  First idea was to create the cap for the 
head from multiple smaller sections. But how to split 
the head shape to multiple sections that can be used 
to create mould(s) similar to the injection moulding 
process was the challenge.  
Fig 4. Tool shape and Tube Ideation (Unver, 2013) 
 
The team then decided to evaluate the design using a 
flat middle section to simplify the moulding process. 
The surface data is taken to a Solid modelling pack-
age to evaluate how and where the mould could be 
generated. The final concept for creating the 3D 
folded cap where two side surfaces are shaped to fit 
the side of the head and the top surface when flat-
tened will be folded on to the head. 
Fig 5. Tool and Patented Tube Design (Unver, 2013) 
 
Initial testing of grooves as seen above proved that 
two parts of the moulding can be created and apply 
to this process.  After modelling the male part of the 
mould as seen above, the female mould is created 
using the male for reference. The two parts are as-
sembled to produce the channels with 1.0mm divid-
ers for minimal space between each cooling channel.  
Although the width of the channels are varied, it is 
calculated to achieve the same section area therefore 
same volume of the channels along the surfaces.  
Fig 6. Tool Printed by EOS (Unver, 2013) 
 
The EOS 3D laser sintering machine with PA2200 
Polyamide material is chosen for tooling as the Laser 
Sintering Machine is available at the University. 
EOSINT P systems with recommended layer thick-
ness is 0.15 mm.  
Thermal properties of the 3D printed tools are one of 
the main reason for choosing this material as melting 
temperature of PA 2200 is around 180C where sili-
cone is heat treated just over 100C during the 
moulding process. Although this was the one of the 
main factors, the required surface quality, print size, 
required minimal thickness value and details, and 
material specification required for heat and pressure 
was another important reason for choosing this laser 
sintering method. This tool was then used by the manu-
facturing partner (Primasil, 2016) where Silicon 
moulding machines used to create the new cap as 
seen in the images below. the moulded silicone 
showed that the method is feasible and can be used 
for cap manufacturing.  
Fig 7. Completed Next Generation Cooling Cap 
(Unver 2013) 
 
 
 
 
 
7 FINDINGS AND CONCLUSIONS 
It is clear that the collaboration between Paxman and 
the research team has resulted an excellent product, 
not only achieving the company’s requirements but 
also the needs of the patients as well. This project 
has shown that the use of RT is the potential future 
of design and development, proving that the tool can 
easily be reprinted and changed at low cost to pro-
vide the best design outcome where low tolerance 
tooling is acceptable. 
The ability to use Rapid Prototyping in tool making 
in the last few years has enabled the boundaries of 
current manufacturing methods to expand, while re-
ducing costs. This process has enabled the creation 
of innovative designs, which were impossible to 
manufacture in few years ago. Designers now can 
create new innovative products using additive manu-
facturing with not following core engineering design 
and manufacturing methods. 
The new cap which is undergoing clinical trials in 
the UK, the US and Japan and has seen very positive 
results in terms of hair retention and patient accepta-
bility. The new cap has also been awarded multiple 
awards, for both the innovation of the design and for 
the collaboration between the company and the uni-
versities design team, showing that the new technol-
ogies provided by universities, KTP’s and other 
available funding can pave the way for new product 
developments and other innovative methods not cur-
rently available to SME’s and other businesses that 
cannot get access to these technologies. 
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